IVA Company Profile and Key Details

IVA has shown sold momentum, gaining 17.98% over the past week and 32.58% over the past quarter, though year-to-date performance is up 38.28%. Short-term trend indicators are bearishly aligned (SMA20 4.3%, SMA50 14.67%, SMA200 42.0%). The stock’s 14-day RSI is 57.52 (neutral), while the ATR of 0.35 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -17.95% below its high and over 145.32% above its low. Average 10-day trading volume of 529.70 thousand shares is slightly above the 3-month average of 412.42 thousand, indicating heightened recent market interest.

Inventiva S.A. has 139.06 million shares outstanding. The public float is 45.54 million shares, elevated short interest at 0.01% of float. This equals 10.01 thousand shares. The short ratio is 0.59 days. Institutional investors hold 5.16% of the float. Insiders own 0.0%.

Inventiva S.A. generated EPS of -$4.08 over the past year. Five-year average earnings growth is -18.31%. Wall Street analysts project EPS growth of 38.39% annually over the next five years. The latest quarter delivered EPS of -$1.90. The next quarter is forecast at -$0.28. Next year's EPS is expected at $12.99. Analyst sentiment is bullish. Analyst rating data shows there are 4 Strong Buy ratings, 7 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $26.00 to $11.00. The high target offers 395.24% upside. The low target suggests 109.52% downside. The mean target is $16.55. This offers 215.24% upside. Inventiva S.A. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended September 25, 2025, missed forecasts by 363.48%. The prior quarter beat by 472.95%. Over the last six quarters, Apple has recorded several small beats. These include 208.03% in March 27, 2024.

Inventiva S.A. (NASDAQ:IVA) closed at $5.25 USD, losing -$0.15 (-2.78%) from the previous close of $5.40. The stock is currently mid-range between its 52-week high and low $2.85 and $7.98. With a market capitalization of about $272.91 million, Inventiva S.A. is classified as a micro-cap and shows market-like volatility (beta ~0.95). Key stats such as the average daily volume over the past year has been around 411.26 thousand shares, volume is running light vs its 52-week average. Headquartered in Daix, None, Inventiva S.A. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Andrew Obenshain, the company employs approximately 114 people and listed since July 10, 2020. Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases.

Inventiva S.A. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.22. This means the shares are trading below this model’s fair value.

Inventiva S.A. trades at a P/E ratio of -8.3, slightly below the S&P 500 average, with a price-to-sales ratio of 53.28 and a price-to-book ratio of -100.81 indicating negative book value, which may reflect financial stress. The P/FCF stands at -2.2, also below market averages.

Our AI price prediction model suggests that Inventiva S.A. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -1.9%, with price expected at $5.15 by May 05, 2026, within a range of $4.90 to $5.42 3-Month Outlook: Projected fall of -51.62%, reaching $2.54 by July 20, 2026, with a range of $2.23 to $2.75. 1-Year Outlook: Projected gain of 552.38%, with price at $34.25 by April 21, 2027, within a range of $36.36 to $41.28.

Inventiva S.A. (NASDAQ:IVA) shares are up 38.28% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Inventiva S.A. trading at a premium to the broader market with a P/E of -8.3. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $18.70, suggesting 256.19% upside. Our AI forecast model points to short-term weakness (-1.9% over two weeks), a medium-term fall (-51.62% over three months), and a longer-term gain (552.38% over one year), with expected trading ranges indicating moderate volatility.